Literature DB >> 31857086

Cells Control BIN1-Mediated Membrane Tubulation by Altering the Membrane Charge.

Sindhuja Gowrisankaran1, Zuoneng Wang2, David G Morgan3, Ira Milosevic1, Carsten Mim4.   

Abstract

The Bridging integrator 1 (BIN1)/Amphiphysin/Rvs (BAR) protein family is an essential part of the cell's machinery to bend membranes. BIN1 is a muscle-enriched BAR protein with an established role in muscle development and skeletal myopathies. Here, we demonstrate that BIN1, on its own, is able to form complex interconnected tubular systems in vitro, reminiscent of t-tubule system in muscle cells. We further describe how BIN1's electrostatic interactions regulate membrane bending: the ratio of negatively charged lipids in the bilayer altered membrane bending and binding properties of BIN1 and so did the manipulation of BIN1's surface charge. We show that the electrostatically mediated BIN1 membrane binding depended on the membrane curvature-it was less affected in liposomes with high curvature. Curiously, BIN1 membrane binding and bending was diminished in cells where the membrane's charge was experimentally reduced. Membrane bending was also reduced in BIN1 mutants where negative or positive charges in the BAR domain have been eliminated. This phenotype, characteristic of BIN1 mutants linked to myopathies, was rescued when the membrane charge was made more negative. The latter findings also show that cells can control tubulation at their membranes by simply altering the membrane charge and through it, the recruitment of BAR proteins and their interaction partners (e.g. dynamin).
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  BAR protein; Membrane bending; t-tubule

Mesh:

Substances:

Year:  2019        PMID: 31857086     DOI: 10.1016/j.jmb.2019.12.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.

Authors:  Dandan Li; Nicholas Schaub; Theresa M Guerin; Tashinga E Bapiro; Frances M Richards; Vicky Chen; Keyur Talsania; Parimal Kumar; Debra J Gilbert; Jerome J Schlomer; Seong-Jin Kim; Rebecca Sorber; Yaroslav Teper; Wendy Bautista; Claudia Palena; Chan-Young Ock; Duncan I Jodrell; Nathan Pate; Monika Mehta; Yongmei Zhao; Serguei Kozlov; Udo Rudloff
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.009

Review 2.  Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.

Authors:  Kenshiro Fujise; Satoru Noguchi; Tetsuya Takeda
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

3.  CryoEM reveals BIN1 (isoform 8) does not bind to single actin filaments in vitro.

Authors:  Zuoneng Wang; Carsten Mim
Journal:  MicroPubl Biol       Date:  2021-06-04

4.  Nanobar Array Assay Revealed Complementary Roles of BIN1 Splice Isoforms in Cardiac T-Tubule Morphogenesis.

Authors:  Lin-Lin Li; Qian-Jin Guo; Hsin-Ya Lou; Jing-Hui Liang; Yang Yang; Xin Xing; Hong-Tao Li; Jing Han; Shan Shen; Hui Li; Haihong Ye; Hao Di Wu; Bianxiao Cui; Shi-Qiang Wang
Journal:  Nano Lett       Date:  2020-08-10       Impact factor: 11.189

5.  Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.

Authors:  Roberto Silva-Rojas; Vasugi Nattarayan; Francisco Jaque-Fernandez; Raquel Gomez-Oca; Alexia Menuet; David Reiss; Marie Goret; Nadia Messaddeq; Valentina M Lionello; Christine Kretz; Belinda S Cowling; Vincent Jacquemond; Jocelyn Laporte
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

6.  Cooperativity of membrane-protein and protein-protein interactions control membrane remodeling by epsin 1 and affects clathrin-mediated endocytosis.

Authors:  Benjamin Kroppen; Nelli Teske; King F Yambire; Niels Denkert; Indrani Mukherjee; Daryna Tarasenko; Garima Jaipuria; Markus Zweckstetter; Ira Milosevic; Claudia Steinem; Michael Meinecke
Journal:  Cell Mol Life Sci       Date:  2020-09-30       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.